Camber-2 (Camber 2)
Moxifloxacin Tablet, Film Coated
Product Images NDC 31722-845
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 31722-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Camber (Camber)
Moxi1 (Moxi1)
Moxifloxacintabs400mg30s (Moxifloxacintabs400mg30s)
This is a medication guide for a tablet containing 400mg of Moxifloxacin hydrochloride (CAMBE R moriloxacin) used for treatment. The guide provides information on storage conditions, dosage, and manufacturer information. It is recommended to dispense the medication guide to each patient by the pharmacist. Contact information for the manufacturer and medication guide is provided.*
Moxifloxacintabs400mg500s (Moxifloxacintabs400mg500s)
This is a description of a medication called Moxifloxacin Tablets, USP. Each tablet contains 400 mg of Moxifloxacin, and the medication guide should be dispensed separately to each patient by the pharmacist. The usual dosage should be seen on the package insert for full prescribing information. The medication should be preserved in a tight, light-resistant container and kept out of the reach of children. The U.S. contact number is 1-866-495-1995. The Medication Guide is available at http://camberpharma.com/medication-guides. The medication is manufactured for Camber Pharmaceuticals, Inc. by Hetero Labs Limited located in India.*
Moxistructure (Moxistructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
